PROCEPT BioRobotics Corporation PRCT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 352.30M | 337.34M | 322.02M | 308.05M | 299.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 352.30M | 337.34M | 322.02M | 308.05M | 299.91M |
| Cost of Revenue | 127.42M | 123.60M | 116.01M | 111.83M | 106.32M |
| Gross Profit | 224.89M | 213.75M | 206.01M | 196.23M | 193.59M |
| SG&A Expenses | 265.57M | 252.07M | 238.70M | 228.81M | 218.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 473.62M | 454.47M | 431.05M | 411.91M | 392.44M |
| Operating Income | -121.31M | -117.13M | -109.03M | -103.86M | -92.53M |
| Income Before Tax | -114.68M | -109.48M | -102.16M | -95.26M | -84.09M |
| Income Tax Expenses | 183.00K | 275.00K | 317.00K | 313.00K | 491.00K |
| Earnings from Continuing Operations | -114.86 | -109.76 | -102.47 | -95.57 | -84.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -114.86M | -109.76M | -102.47M | -95.57M | -84.58M |
| EBIT | -121.31M | -117.13M | -109.03M | -103.86M | -92.53M |
| EBITDA | -113.34M | -110.08M | -102.38M | -97.47M | -86.40M |
| EPS Basic | -2.03 | -1.95 | -1.83 | -1.72 | -1.54 |
| Normalized Basic EPS | -1.30 | -1.25 | -1.14 | -1.07 | -0.96 |
| EPS Diluted | -2.03 | -1.95 | -1.83 | -1.72 | -1.54 |
| Normalized Diluted EPS | -1.30 | -1.25 | -1.14 | -1.07 | -0.96 |
| Average Basic Shares Outstanding | 226.98M | 225.38M | 223.75M | 222.16M | 219.93M |
| Average Diluted Shares Outstanding | 226.98M | 225.38M | 223.75M | 222.16M | 219.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |